Sort
8,912 grants matching “sars cov 2”
Inhibition of COVID-19 associated acute fibrin deposition in lung
$277,640Peter D. Sun · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
CEIRR Data Processing and Communications Center Activities for SARS-CoV-2
$277,285Stephan Bour · Digital Infuzion, Inc. · N01 · FY2023 · AI
IMMUNOGENIC SUGAR MOIETIES OF HCMV
$277,226Denong Wang · Sri International · R21 · FY2017 · AI
Role of SARS-CoV-2 Spike Protein and Accessory ORFs in the immune pathogenesis of COVID-19
$277,197John H Kehrl · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Clinical Core
$277,117Viviana A Simon · Icahn School Of Medicine At Mount Sinai · U19 · FY2023 · AI
East Africa International Epidemiology Database to evaluate AIDS (IeDEA) Regional Consortium
$276,896Kara Kay Wools-Kaloustian · Indiana University Indianapolis · U01 · FY2025 · AI
Core 06: Biomedical Informatics Core
$276,877Lucio Miele · Lsu Pennington Biomedical Research Ctr · U54 · FY2022 · GM
Clinical Validation of Serum Neurofilament Light as a Biomarker of Traumatic Axonal Injury
$276,461Ramon R Diaz-Arrastia · University Of Pennsylvania · U01 · FY2021 · NS
STTR Phase I: Development of an Intranasal Vaccine for COVID-19
$276,000Maoqi M Feng · Dynamic Entropy Technology, Llc · · FY2020 · TIP
SBIR Phase I: Aerogels Derived from Genetically Engineered Microbial Cells
$276,000Lina M Gonzalez · Spadxtech Llc · · FY2021 · TIP
SBIR Phase I: Handheld Detection of COVID-19 With Simple Biosensor Devices for Environmental Monitoring
$276,000Khalid K Alam · Stemloop, Inc. · · FY2020 · TIP
SARS-CoV-2 infection of non-human primates
$275,820Daniel Barber · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
Rapid Point-of-Care Molecular Test for SARS-CoV-2 and Influenza A/B
$275,766Season S-S Wong · Ai Biosciences, Inc. · R43 · FY2022 · GH
Pan-COVID Therapeutic
$275,766Bo Yu · Larix Bioscience, Llc · R43 · FY2022 · GH
Rapid COVID-19 Mutation Discrimination Test for Global SARS-CoV-2 Variant Surveillance
$275,766Janet L Huie · Jan Biotech, Inc. · R43 · FY2022 · GH
Generating fast-on rate reagents for lateral flow assays to detect HCV
$275,606Brian Kenneth Kay · Tango Biosciences, Inc. · R43 · FY2023 · AI
SBIR PA22-176 - RNA aptamers for rapid response to COVID-19 variants
$275,482Hong Yan Liu · Dotquant, Llc · R43 · FY2023 · IP
Biophysical Characterization of the Coiled-Coil Domains
$275,451Robert S Hodges · University Of Colorado Denver · P01 · FY2006 · AI
Covid-19 transmission, testing, and vaccination dynamics within migrant worker social networks
$275,261John Schneider · University Of Chicago · R21 · FY2024 · AI
Administrative Core
$275,223David B. Weiner · Wistar Institute · P01 · FY2022 · AI
Menstrual health during the Covid-19 pandemic: A longitudinal study among young people with and without endometriosis
$274,576Asgerally T. Fazleabas · Michigan State University · R01 · FY2021 · HD
Development of Broad Coronavirus Immunity Targeting the Fusion Peptide
$274,544Daniel Kulp · Wistar Institute · R21 · FY2021 · AI
What is the human antibody response to measles virus vaccination?
$274,500Erica Ollmann Saphire · La Jolla Institute For Immunology · R21 · FY2024 · AI
Experimental identification of functional GWAS variants linked to COVID-19 severity in immune cells
$274,500Benjamin Joachim Schmiedel · La Jolla Institute For Immunology · R21 · FY2024 · AI
SARS-CoV-2 pathogenesis and countermeasures
$273,653Emmie De Wit · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI